CMS Approves Coverage for PQ Bypass TORUS 2 IDE Trial – Endovascular Today
December 19, 2019—PQ Bypass Inc. announced it has received approval for coverage from the Centers for Medicare and Medicaid Services (CMS) for t
Related Articles
Exploring the Potential for a “Response Team” Concept in Deep Vein Thrombosis – Endovascular Today
Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, barriers to adoption, patient selection and…
Aptyx Acquires Medical Murray’s Facility, Forms Aptyx Interventional Systems – Cardiac Interventions Today
January 21, 2025—Aptyx, a Tempe, Arizona–based developer and manufacturer of complex components and devices for the life sciences, announc
Front Line’s COBRA-OS for REBOA Procedures Launched in United Kingdom – Endovascular Today
January 23, 2025—Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark-approved COBRA-OS—Control of Bl
Beyond Chronicity: Clot Characteristics and How They Drive Decisions in Deep Venous Disease – Endovascular Today
The knowns and unknowns about venous thrombus biology as it relates to in-stent restenosis and how these results drive patient care.
Venova Begins VENOS-2 EFS of Velocity pAVF System – Endovascular Today
January 21, 2025—Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o
Concept Medical’s SirPAD Trial of MagicTouch PTA Device Completes Enrollment – Endovascular Today
January 20, 2025—Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu
Home
Viz.ai is the leading AI care coordination platform for disease detection and workflow optimization. Trusted by 1,300 hospitals.
Optimizing Deep Venous Treatment – Endovascular Today
It is a wonderful honor to serve as Guest Editor of this venous disease–focused issue of Endovascular Today and collaborate with its outstan
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for ELITE-BTK Pivotal Trial – Endovascular Today
January 17, 2025—R3 Vascular Inc. recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK pivotal tr
Concept Medical’s MAGICAL BTK IDE Trial Begins Enrollment – Endovascular Today
January 16, 2025—Concept Medical Inc., announced the enrollment of the first patient in the pivotal MAGICAL BTK randomized controlled trial, whi